Influenza A (A/New Caledonia)

Products_type

Native Protein
Products_short_name

[Influenza A Strain A/New Caledonia/20/99 IVR 116 (H1N1)]
Products_name_syn

[Influenza Virus, Type A (H1N1), Strain A/New Caledonia/20/99 IVR116]
Specificity

Influenza A Strain A/New Caledonia/20/99 IVR 116 (H1N1)
Purity

>90% pure (SDS-PAGE). Ultracentrifugation using 10-40% sucrose gradient
Form

Purified, Liquid
Concentration

1mg/ml (BCA method)
Storage_stability

Upon receipt, store at -20 degree C. Avoid multiple freeze/thaw cycles.
Tested_application

EIA/ELISA
Description

Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.

Gene target

Influenza A/New Caledonia
Short name

Influenza A (A/New Caledonia)
Host

Allantoic fluid of 10 day old embryonated eggs, inoculated with Influenza A virusStrain: A/New Caledonia/20/99 IVR 116
Species

Influenza, Influenza
Alternative name

Influenza A (A/New Caledonia)
Virus

influenza